
Best Of: Why companies don't want to list in the UK anymore
Behind the Money
00:00
Introduction
This chapter explores the fundraising challenges faced by Amunocor, a British biotech firm, as they turned to US investors for additional funding. It also highlights the positive results from their clinical trial in 2020.
Transcript
Play full episode